Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“A drug with "potential for abuse" short of "high" but no "accepted" medical use does not fit into any of the CSA schedules.”
Mostly supportedConfidence: MODERATE

Reasoning

The evidence quotes the article stating that a drug with "potential for abuse" short of "high" and no "accepted" medical use does not fit into any CSA schedule. This aligns with the claim, indicating support. No contradictory evidence is presented.

On confidence: The claim is directly echoed in the provided article, which cites a GAO report highlighting gaps in the statutory definitions. However, the source is a secondary news analysis rather than the primary statutory text, limiting certainty.

Important context

The claim relies on the interpretation of the Controlled Substances Act's criteria, which the article argues are vague and may leave such a drug unclassifiable under current schedules.

Evidence

Supporting (2)

Limitations

The evidence is limited to a single news article summarizing a GAO report; the actual statutory language or official agency guidance is not examined. Therefore, the conclusion cannot be fully verified against primary legal sources.

Last verified:
Oct 2, 2026, 4:28 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum